Our lives have suddenly been forced into the core of the digital world this year. We are still able to work and socialise globally because of the advancement in technology. Despite the situation we are in today, scientists will continue to advance the technology to aid the human race.
The Covid-19 pandemic is an important reminder of the long-term importance of investing in and building human capital – health, knowledge, capabilities, skills and resilience - that are critical to ensuring that everyone has the opportunity to reach their full potential. This is especially true in Africa, which is home to the world’s youngest population and also to some of the toughest human capital challenges.
Synthetic biology is the principle of synthesising DNAs and designing genetic circuitry to enhance or repurpose cellular functions. In recent years, advancements in this field of science have expanded the capabilities of microbial fermentation to beyond just brewing and food processing. Through microbial and mammalian cell engineering, bio-manufacturing has been repurposed for a wide variety of end products from fragrance to pharmaceuticals.
If this global pandemic has taught us anything, it is that digital healthcare solutions are increasingly becoming a mainstream offering. Key services like telehealth, clinical decision support and digital access to personal medical records, are just some examples that healthcare is moving away from being a predominantly encounter-based (and physical) care model.
Topics: MedTech / HealthTech / BioTech
The Entrepreneurial Scientist brings research out of the lab to start a business. The challenges come hard and fast – market and early adopter identification; user needs specification; product development; pilots or trials; go-to-market preparations; funding; critical hiring at the initial phase, etc.
Deep Tech spans from scientific discovery or engineering innovation and has the potential to be disruptive. Deep Tech promises solutions to real-life problems within healthcare, energy, food and sustainability, amongst others.
The journey for scientists to start Deep Tech companies can be daunting and risky, but there are no rewards without risks. Discover what it takes to turn your research into a successful business at this session with Innovators Under 35 alumni, Dr Benjamin Tee, and his fellow entrepreneurial scientist, Dr Harold Soh.
As most of society has experienced, the pandemic has affected many economies across the globe. For economies to emerge stronger post-COVID-19, resilience and reliability are key. Countries will have to uncover and master major trends reshaping the global economy and hasten their digitals shifts and structural transformations.
According to the Biotechnology Innovation Organisation, BioTech is “technology based on biology – harness[sing] cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet.” More than just a tool for human health, BioTech is involved in many industries including energy and fuel, and agriculture and food, where innovations in the field helps address some of the world’s most pressing issues.
While most of the available health care diagnostics that use artificial intelligence (AI) technologies are extraordinarily powerful, the adoption of these algorithms has been slow because results are difficult to verify, and they also do not include explanations of why a patient has a certain disease or disorder. However, a new type of algorithm called “explainable AI” (XAI) can be easily understood by humans. As a result, XAI is being increasingly relevant in healthcare, making it more likely that healthcare providers will actually use the associated diagnostics.
Deep Tech – artificial intelligence, data science, medical technologies, quantum technologies, etc. holds the promise to improve the human condition and help address many grand challenges – in Health, Food, Climate Change and Sustainable Development, that humanity is facing.
With the purpose to connect the science, technology and innovation ecosystems between Japan and Singapore for knowledge sharing and collaboration opportunities, SGInnovate and the Japan Science & Technology Agency are co-presenting a series of talks by notable startups, researchers and corporate innovators on various deep tech topics.